Alefacept in the treatment of psoriatic nail disease: a proof of concept study.

Journal of drugs in dermatology : JDD

Volumn 5, Issue 4, 2006, Pages 339-340

  Parrish, Charles A ^a   Sobera, Jenny O ^a   Robbins, Courtney M ^a   Cantrell, Wendy C ^a   Desmond, Renee A ^a   Elewski, Boni E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; HYBRID PROTEIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG ADMINISTRATION; HOSPITALIZATION; HUMAN; MIDDLE AGED; NAIL DISEASE; PROGNOSIS; PSORIASIS; TIME; TREATMENT OUTCOME;

ADULT; DRUG ADMINISTRATION SCHEDULE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; NAIL DISEASES; PROGNOSIS; PSORIASIS; RECOMBINANT FUSION PROTEINS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 33748889792     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)